CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revenues	$ 2,739,439	$ 994,265
Cost of revenue	1,384,145	1,226,321
Gross profit (loss)	1,355,294	(232,056)
Operating expenses:
Selling and marketing	1,421,127	713,972
Research and development	181,303	343,712
General and administrative	3,732,749	2,568,227
Impairment of related party non-marketable securities	0	50,000
Amortization and depreciation	538,761	570,247
Total operating expenses	5,873,940	4,246,158
Operating loss	(4,518,646)	(4,478,214)
Other income (expense):
Unrealized loss on derivative liabilities	(155,027)	(2,758,488)
Unrealized loss on marketable securities	(450)	(2,400)
Loss on settlement of debt	(15,724)	(1,664,281)
Other income	0	750
Interest expense, net	(917,992)	(675,997)
Total other income (expense)	(1,089,193)	(5,100,416)
Net loss	(5,607,839)	(9,578,630)
Dividend on Series A Convertible preferred stock	(75,206)	(80,000)
Net loss available to common stockholders	$ (5,683,045)	$ (9,658,630)
Net loss per common share-basic and diluted	$ (0.05)	$ (0.1)
Weighted average common shares outstanding-basic and diluted	117,335,917	98,905,556